BANK OF AMERICA CORP /DE/ - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 19 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$8,000
-95.9%
10,000
-95.3%
0.00%
Q3 2021$193,000215,0000.00%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 157,390,000$143,842,0002.81%
PFM Health Sciences, LP 48,150,000$44,256,0001.30%
DAFNA Capital Management LLC 1,500,000$1,375,0000.36%
SILVERBACK ASSET MANAGEMENT LLC 2,500,000$2,303,0000.34%
Context Capital Management, LLC 2,979$2,707,0000.28%
ADVENT CAPITAL MANAGEMENT /DE/ 9,667,000$8,842,0000.16%
DeepCurrents Investment Group LLC 3,700,000$3,423,0000.10%
LOOMIS SAYLES & CO L P 1,249,328$14,242,0000.02%
SG Americas Securities, LLC 22,600$2,255,0000.01%
LAZARD ASSET MANAGEMENT LLC 9,218,000$8,376,0000.01%
View complete list of AERIE PHARMACEUTICALS INC shareholders